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Dear Editor,
Burning mouth syndrome (BMS) is a complex and mul-
tifactorial clinical disorder characterized by a continuous 
burning and itching sensation in the absence of oral lesions 
that would account for the discomfort. (1) The estimated 
prevalence is 0.7-4.5%. (1,2) While BMS can affect many 
areas in the mouth, the tongue is the most commonly affec-
ted area.(1) Almost 90% of affected patients are women 
in the aged 50-70 years. (1,2) The etiopathogenesis is not 
known, although many studies have related the syndrome 
with pharmacotherapy (3), and proposed treatments have 
been aimed at hypothetical etiological factors, or simply in-
tended to lessen or eliminate the symptoms. (4-6) Proposed 
management includes patient information, the correction 
of habits, protection of the oral mucosa and the prescrip-
tion of rinses and antiseptic products.(5) Benzydamine (an 
antiinflammatory and antiseptic drug) in 0.15% solution 
has also been proposed, but with no significant degree of 
effectiveness. The same can be said of rinses with local 
anesthetics such as lidocaine. At present, use is being made 
of psychoactive drugs such as trazodone, paroxetine and 
sertraline. Tricyclic antidepressants such as amitriptyline 
(at a dose of 10-150 mg/day) or nortriptyline; anxiolytics 
such as diazepam (6-15 mg/day) and other benzodiazepine 
derivates such as clonazepam (0.25-1 mg/day) have been 
shown to be effective. Studies have also demonstrated 
some efficacy with alpha-lipoic acid for the treatment of 
BMS symptoms. (5, 6)
A review of the literature yielded no previous studies of 
the behavior of dental professionals in relation to BMS. 
We thus decided to evaluate the knowledge, attitudes and 
practices among Spanish dentists in relation to suspected 
BMS, attempting to identify differences in therapeutic 
practice and the possible influence of the years of pro-
fessional experience, gender, work setting (private, public) 
and professional grade (dental surgeons or physicians spe-
cialized in dental care). Sampling surveys were used in the 
study, which was approved by the Ethics Committee of the 
University of Murcia. The study design was based on the 
list of the affiliated dentist provided by the General Stoma-
tological and Odontological Council of Spain, 2005. The 
size of the sample was defined by adopting the random 
extraction method, assuming a confidence interval of 95%, 
a maximum variance of P=Q=50 and a sampling error of 
less than 3%. The initial sample was chosen by a stratifi-
cation process, using individual provinces as strata. The 
inclusion criterion was general dentist in practice and the 
exclusion criterion was oral surgeons, orthodontics, etc. 
Of the 1022 dentists chosen, 840 replied (74%). The study 
was conducted between January and November 2006, and 
assurances of anonymity were given. The questionnaire 
comprised several item blocks and was pre-tested with 30 
dentists to improve the validity of responses.
A first item block evaluated socio-demographic aspects 
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and the years of professional experience, gender, work 
setting (public and private) and grade (dental surgeons 
or physicians specialized in dental care). A second item 
block explored therapeutic attitudes in relation to patients 
with BMS (patient information on BMS, drug treatment 
(anxiolytics, antidepressants) and rinses). 
Males slightly out numbered females (50.4% versus 
48.1%). The mean age of the global series was 27.99 years, 
with standard deviation (SD) = 9.967. As to the variable 
“years of professional experience”, the mean was found 
to be 12.25 (SD = 8.432). Lastly, in relation to the work 
setting, 97.3% of the interviewed professionals were de-
dicated to private practice, and 8.8% to public practice. 
In turn, 67.1% of interviewed professionals had studied 
dentistry in dental schools, while 32.9% held a degree in 
medicine, with stomatology as a specialty. 
The frequency with which the professionals diagnosed 
BMS was not influenced (p=0.195) by the years of pro-
fessional experience (12.16±8.35), although it should be 
noted that a greater number of years in practice led to a 
higher number of cases being diagnosed on a monthly 
basis (>3 cases). However there was a significant relation 
between public and private practice (p=0.000). 
A high percentage (44.6%) of professionals referred the 
patients to specialised centres, while those who treated 
the pathology themselves tended to have more experience 
(p=0.02). There was no relation in this respect with gender 
or place of work (private or public). 
Among the non-exclusive options of treatment and the 
results should be noted the information given to the patient 
concerning the illness (53.57%), the use of mouth washes 
(41.66%) and psychotropic drugs (17.02%), while only 
8.57% of dentists affirmed that the treatments available 
were effective for BMS syndrome. 
No significant gender differences were observed regarding 
the management of BMS patients, except as refers to the 
use of systemic drugs (used by 15.2% of the males versus 
11.3% of the females; p=0.01) (p<0.05). No statistically 
significant relation was observed between the treatment 
used and the work setting, although the most experienced 
dentists (p=0.024) opted for systemic treatment. 
As regards professional grade, odontologists were more 
inclined to provide information to the patient (43.7% 
versus 41.3% among medical doctors specialized in den-
tistry; p=0.000), and to prescribe rinses (e.g., triclosan or 
chlorhexidine) (34.1% versus 31.9%; p=0.02). In contrast, 
the stomatologists were more inclined to treat glossodynia 
with anxiolytics or antidepressants (16.2% versus 11.8% 
among the dental surgeons; p=0.000) (see Table I).
We are dealing with a syndrome of diverse etiology and 
still unknown in many respects. Such a situation requi-
res the use of agreed protocols or guidelines about the 
treatments available for a disease that Spanish dentists in 
general practice are increasingly faced with. 
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Table I. Statistical significance between the way in which BMS is treated and socio-demographic items.
Experience (years of professional experience), gender (males and females), work setting (public private and mixed) and profes-
sional grade (odontologist and stomatologist)..
* statistically significant  p<0.05
Treatment alternatives 
Experience Gender Work setting Grade
Patient information
T=-2.259 Χ2=0.475 Χ2=7.876 Χ2=17.459
P=0.024* P=0.491    P=0.019* P=0.000*
Anxiolytics/antidepressants
T=-4.083 Χ2=6.264 Χ2=0.645 Χ2=18.431
P=0.000* P=0.012* P=0.724 P=0.000*
Chlorhexidine, triclosan, rinses
T=-2,279 Χ2=1.290 Χ2=3.507 Χ2=10.012
P=0.023* P=0.256 P=0.173 P=0.002*
Effectiveness of current 
treatments
T=-0.962 Χ2=2.008 Χ2=0.794 Χ2=5.062
P=0.337 P=0.366 P=0.939 P=0.080
Other treatments
T=-0.608 Χ2=0.097 Χ2=5.005 Χ2=0.031
P=0.543 P=0.756 P=0.082 P=0.860
